Sumitomo Chemical Advanced Medical Solutions America LLC (SC-AMSA)

SC-AMSA, a Sumitomo Chemical group company located in the Boston biotech hub, provides high-purity custom gRNAs for pharmaceutical R&D. We specialize in 1 mg-scale synthesis, delivering >80% purity for 100–140mer sequences. With local, hands-on technical support and shared synthetic and analytical methods with Sumitomo Chemical, we enable a seamless transition from early discovery to large-scale GMP manufacturing.

www.sc-amsa.com

SC-AMSA is partnering with the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)
SC-AMSA is partnering with the 7th Genome Editing Therapeutics Summit 2026 in Boston, MA (September 28-30)